Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?


Pixabay / NeuPaddy / CC0 Public Domain

In the red-hot world of marijuana stocks, there can be no question that GW Pharmaceuticals (NASDAQ:GWPH) reigns supreme. While most other marijuana-related stocks trade for pennies in the wild west of OTC markets, GW Pharmaceuticals trades on the Nasdaq at a market cap of roughly $2.5 billion.

However, as success always breeds competition, another clinical stage biotech is hot on GW’s heels. Could small-cap biotech Zogenix (NASDAQ:ZGNX) be the biggest threat to GW?

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts